As the disease progresses to HGCIN and SCC, increased synthesis of HLA-DRA protein recruits immune support via CD4+ T cells, leading to more favourable CD8+ T-cells responses and thus preventing tumour invasion. The gene discussed is CD8A; the disease is neoplasm.